Welcome to Inventiva Pharma

No front page content has been created yet.

Pipeline

Latest News

IVA337 delivers significant therapeutic advances
IVA337 delivers significant therapeutic advances in fibrosis, a major
Come meet us at the 4th systemic sclerosis world
Inventiva will attend the upcoming systemic sclerosis world congress
Professor Yannick Allanore, principal coordinator
Professor Yannick Allanore, principal coordinator of the FASST trial

Drug Discovery Capabilities